Amyloid-beta 42/40 ratio

There are 165 papers on amyloid-beta 42/40 ratio in aging research: 5 trials and 137 observational studies in people, 8 in animals, 10 reviews. The newest story, Nov 19, 2026: “Alzheimer’s blood tests agreed less on individual change”.

Biomarker

165 papers study it1 more mentions it56 findings

9 new papers in 30 daysSee all 166 papers on amyloid-beta 42/40 ratio

At a glance

A lower amyloid-beta 42/40 ratio is associated with incident mild cognitive impairment and dementia in a cohort of women. Human studies also link the ratio with amyloid PET in cognitively unimpaired people, but a study in people undergoing hemodialysis finds no clear link with cognition.

56 findings in 47 papers from 2017 to 2026, 15 of them since April 2026

“In ε4 carriers, decreases in Aβ−42/40 became steeper after age 50”
APOE ε4 carriership status enhances age-related changes in Alzheimer’s disease plasma biomarkers concentrationsNature communications2026doi:10.1038/s41467-026-78723-2
  • Human trial5
  • Humans137
  • Animals8
  • In silico1

Interventions

7

Processing delay

upin humans1no changein humans1

1 study
  1. Processing delay is linked with higher amyloid-beta 42/40 ratio in humans.

    HumansPlasmaUp to 72 hoursn = 41

  2. Processing delay was not clearly linked with amyloid-beta 42/40 ratio in humans.

    HumansSerumUp to 48 hoursn = 41

More on Processing delay

Dichlorodiphenyldichloroethylene

downin humans1

1 study
  1. Dichlorodiphenyldichloroethylene is linked with lower amyloid-beta 42/40 ratio in humans (adjusting for sex, race, education, and APOE ε4 status) (β=-0.079; 95% CI, -0.133 to -0.024; P=0.005).

    Humansadjusting for sex, race, education, and APOE ε4 statusplasman = 179

More on Dichlorodiphenyldichloroethylene

Sleep fragmentation

downin humans1

1 study
  1. Sleep fragmentation is linked with lower amyloid-beta 42/40 ratio in older adults with AHI4% < 5 (ρ=-0.398, p = 0.045).

    Humansin older adults with AHI4% < 5plasman = 64

More on Sleep fragmentation

Aha life's essential 8

downin humans1

1 study
  1. Aha life's essential 8 is linked with lower amyloid-beta 42/40 ratio in humans (intermediate or poor vs ideal LE8) (adjusted mean difference: -2.37, 95% CI: -2.38 to -2.36 and -2.38, 95% CI: -2.40 to -2.36, respectively).

    Humansintermediate or poor vs ideal LE8n = 1,406

More on Aha life's essential 8

Usual diet

downin humans1

1 study
  1. Usual diet decreases amyloid-beta 42/40 ratio in humans (-2.8%, beta = -0.012, SE = 0.005, p = 0.024).

    Human trialplasma3 yearsn = 504

More on Usual diet

Yoga

upin humans1

1 study
  1. Yoga increases amyloid-beta 42/40 ratio in Alzheimer's disease patients.

    Human trialin Alzheimer's disease patients12 weeksn = 30

More on Yoga

Selenium

upin humans1

1 study
  1. Selenium is linked with higher amyloid-beta 42/40 ratio in humans.

    Humansn = 469

More on Selenium

Effects

6

Cognitive function

no changein humans1upin humans1mediatesin humans1

3 studies
  1. Amyloid-beta 42/40 ratio was not clearly linked with cognitive function in humans (patients undergoing hemodialysis).

    Humanspatients undergoing hemodialysisserumn = 384

  2. Amyloid-beta 42/40 ratio is linked with better cognitive function in humans among non-Hispanic (NH) whites.

    Humansamong non-Hispanic (NH) whites

  3. Amyloid-beta 42/40 ratio is linked with cognitive function in humans (osteopenia).

    Humansosteopenia

Cognition and depressive symptoms

no changein humans1

1 study
  1. Amyloid-beta 42/40 ratio was not clearly linked with cognition and depressive symptoms in humans (Spanish-speaking Latino adults without dementia; adjusted for age, sex, and education).

    HumansSpanish-speaking Latino adults without dementia; adjusted for age, sex, and educationplasman = 122

Prospective memory lapses

no changein humans1

1 study
  1. Amyloid-beta 42/40 ratio was not clearly linked with prospective memory lapses in humans (p > .123).

    Humansbloodn = 275

Learning score

no changein humans1

1 study
  1. Amyloid-beta 42/40 ratio was not clearly linked with learning score in humans (cognitively unimpaired).

    Humanscognitively unimpaired

Mini-Mental State Examination score

mediatesin humans1

1 study
  1. Amyloid-beta 42/40 ratio is linked with mini-Mental State Examination score in humans.

    Humansassociation between blood cathepsin L and MMSE score in Aβ+ cognitively impaired participantsplasma

Frailty

no changein humans1

1 study
  1. Amyloid-beta 42/40 ratio was not clearly linked with frailty in humans (without adjusting for APOE ε4 genotype).

    Humanswithout adjusting for APOE ε4 genotypen = 477

Upstream

7

APOE

downin humans1

1 study
  1. APOE is linked with lower amyloid-beta 42/40 ratio in humans (cognitively unimpaired older adults) (p < 2e-16).

    Humanscognitively unimpaired older adultsplasman = 1,149

More on APOE

TOMM40

downin humans1

1 study
  1. TOMM40 is linked with lower amyloid-beta 42/40 ratio in humans (cognitively unimpaired older adults) (p = 8.66e-6).

    Humanscognitively unimpaired older adultsplasman = 1,149

More on TOMM40

Deep medullary vein score

downin humans1

1 study
  1. Deep medullary vein score is linked with lower amyloid-beta 42/40 ratio in humans (dementia-free older adults) (β = -0.11; 95% CI -0.20‒-0.02).

    Humansdementia-free older adultsn = 903

More on Deep medullary vein score

Hearing loss

no changein humans1

1 study
  1. Hearing loss was not clearly linked with amyloid-beta 42/40 ratio in humans.

    Humans

Myostatin

no changein humans1

1 study
  1. Myostatin was not clearly linked with amyloid-beta 42/40 ratio in Black men and women.

    Humansin Black men and women

More on Myostatin

Glutathione peroxidase

downin humans1

1 study
  1. Glutathione peroxidase is linked with lower amyloid-beta 42/40 ratio in humans.

    Humansn = 469

More on Glutathione peroxidase

Delirium

no changein humans1

1 study
  1. Delirium was not clearly linked with amyloid-beta 42/40 ratio in humans (postoperative) (ρ = .394, p = .18).

    Humanspostoperativecerebrospinal fluidn = 13

More on Delirium

Associations

30

Cognitive function

downin humans2upin humans1

3 studies
  1. Amyloid-beta 42/40 ratio is associated with cognitive function in humans.

    Humansn = 1,181

  2. Amyloid-beta 42/40 ratio predicts cognitive function in humans (subjective cognitive decline) (B = 1.35, SE = 0.62, p = .030).

    Humanssubjective cognitive decline5 yearsn = 203

  3. Amyloid-beta 42/40 ratio is associated with cognitive function in humans (multiple sclerosis) (Coeff = -0.021; 95 %CI = -0.036, -0.006; p = 0.007).

    Humansmultiple sclerosisplasman = 83

Frailty

downin humans1upin humans1HR 2.63

2 studies
  1. Frailty is associated with amyloid-beta 42/40 ratio in humans (undergoing elective surgery) (b = -0.11, 95% CI [-0.21; -0.01]).

    Humansundergoing elective surgeryn = 786

  2. Amyloid-beta 42/40 ratio is linked with a higher risk of frailty in humans (adjusted for APOE ε4 genotype; lower vs upper quartile (≤0.103 vs >0.123)) (HR=2.63; 95% CI, 1.00 to 6.89).

    Humansadjusted for APOE ε4 genotype; lower vs upper quartile (≤0.103 vs >0.123)n = 477

MME

mixedin humans1

1 study
  1. MME is associated with amyloid-beta 42/40 ratio in humans (Midwestern Amish cohort).

    HumansMidwestern Amish cohortplasma

More on MME

APOE

downin humans1

1 study
  1. APOE is associated with amyloid-beta 42/40 ratio in humans (APOE ε4 carriers compared with non-carriers).

    HumansAPOE ε4 carriers compared with non-carriersplasma

    Alzheimer’s risk variant linked to steeper blood-marker changes

    Nature communications

More on APOE

p-tau217-negative/amyloid PET-positive status

downin humans1

1 study
  1. p-tau217-negative/amyloid PET-positive status is associated with amyloid-beta 42/40 ratio in humans (Cognitively normal ADNI participants; p-tau-/PET+ versus p-tau-/PET-).

    HumansCognitively normal ADNI participants; p-tau-/PET+ versus p-tau-/PET-plasman = 475

    Mismatched Alzheimer's tests linked to distinct risk patterns

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on p-tau217-negative/amyloid PET-positive status

CCDC6

mixedin humans1

1 study
  1. CCDC6 is associated with amyloid-beta 42/40 ratio in humans (promoter/enhancer variants) (MAF = 0.27).

    Humanspromoter/enhancer variantsbloodn = 2,224

More on CCDC6

Social isolation

downin humans1

1 study
  1. Social isolation is associated with amyloid-beta 42/40 ratio in humans (New-onset severe social isolation) (β -0.25).

    HumansNew-onset severe social isolationplasman = 3,862

    Social isolation linked to blood marker of nerve-cell injury

    medRxiv : the preprint server for health sciencesPreprint

More on Social isolation

Circadian syndrome

mixedin humans1

1 study
  1. Circadian syndrome is associated with amyloid-beta 42/40 ratio in humans (Pnonlinear = 0.029).

    Humans

More on Circadian syndrome

Incident mild cognitive impairment and dementia

upin humans1

1 study
  1. Amyloid-beta 42/40 ratio is associated with incident mild cognitive impairment and dementia in humans (lower ratio).

    Humanslower ratiomean 18-year follow-upfemalesn = 2,467

More on Incident mild cognitive impairment and dementia

Hypertension

downin humans1

1 study
  1. Amyloid-beta 42/40 ratio is associated with hypertension in humans (mild cognitive impairment).

    Humansmild cognitive impairmentplasman = 176

More on Hypertension

All 30

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 29Jan 2026: 10Feb 2026: 5Mar 2026: 2Apr 2026: 6May 2026: 7Jun 2026: 6Jul 2026: 3Aug 2026: 7Sep 2026: 1Oct 2026: 6Nov 2026: 890 papers in 12 months
medRxiv

Alzheimer’s blood tests agreed less on individual change

With 1 meaning perfect agreement, tests scored 0.44 for individual rates of change in one marker versus 0.75–0.95 for levels across four markers.With 1 meaning perfect agreement, tests scored 0.44 for individual rates of change in one marker versus 0.75–0.95 for levels across four markers.

Preprint: cohort · 393 peopleAlzheimer's disease
bioRxiv

Aging linked to blood and brain changes in chimpanzees

A cross-sectional study of 154 chimpanzees aged 12–57 found age-related blood and brain patterns resembling those seen in humans.A cross-sectional study of 154 chimpanzees aged 12–57 found age-related blood and brain patterns resembling those seen in humans.

Preprint: cross-sectional studyMechanisms
Alzheimer's & Dementia

Mismatched Alzheimer's tests linked to distinct risk patterns

An observational analysis of 594 and 475 cognitively normal adults found different blood-protein patterns depending on which Alzheimer's test was positive.An observational analysis of 594 and 475 cognitively normal adults found different blood-protein patterns depending on which Alzheimer's test was positive.

Cohort · 332 peopleBiomarkers

See all 166 papers on amyloid-beta 42/40 ratio